Our Belgian partners host the Bioregate Forum for the first time
After two editions in Nantes, Bioregate Forum, the European Regenerative Medicine Forum, took on a European dimension. It was in Louvain-la-Neuve, Belgium, that the highlight of... View Article
BioMAdvanced Diagnostics raises €1,7 million
The investment to be used to develop its diagnostics solutions and contribute to improving the life of patients having received... View Article
Valneva provides further update on its COVID-19 activities
Valneva, a specialty vaccine company, today announced a further update on its COVID-19 vaccine activities. The company had previously communicated... View Article
Pherecydes Pharma successfully completes €3.1 million capital increase
Pherecydes Pharma, a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, today announces the... View Article
Same™ by i-SEP medical device has obtained the CE mark and started marketing
i-SEP announces the CE marking and marketing of its autotransfusion medical device: same™ by i-SEP. For the past several months... View Article
Biofortis is part of the national project Le French Gut, to accelerate the science of the microbiota
READ THE PRESS RELEASE Biofortis as a unique full service CRO providing Nutrition Clinical Trials, Microbiome Investigation and Data Science... View Article
Perha Pharmaceuticals is a laureate of the European Innovation Council (EIC) Accelerator Programme and could receive an €8 M in funding for the development of its lead candidate Leucettinib-21
Perha Pharmaceuticals has been selected by the European Commission under the European Innovation Council (EIC) Accelerator Programme for the development... View Article
Pherecydes Pharma announces a first registration of its phagogram as an in vitro diagnostic test in accordance with EC Directives
Pherecydes Pharma, a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, today announces the registration... View Article
Naobios x GenSensor: a partnership for bioprocess optimization
A partnership between three members of Atlanpole Biotherapies: Naobios, Clean Biologics and GenSensor. The collaboration aims at bioprocess optimization through joint bioproduction expertise. Two companies providing expert... View Article
VitaDX signs a strategic partnership with the XPath group for the use of its VisioCyt® software solution
XPath, a group of medical specialists in pathological anatomy and cytology, a player in this medical specialty that has made... View Article